{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-104028","form_type":"8-K","ticker":"TTRX","cik":"0002023016","company_name":"Turn Therapeutics Inc.","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.348846+00:00","generated_at":"2026-05-17T01:26:21.725594+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Turn Therapeutics enters global supply, development, and license agreement with Medline","bullets":["Agreement covers development, manufacture, and commercialization of products using Turn's PermaFusion delivery platform.","Medline is the largest provider of medical-surgical products and supply chain solutions in the U.S.","Financial terms, product categories, and development timelines remain confidential per agreement terms.","CEO Bradley Burnam calls partnership a 'transformative milestone' to accelerate entry into professional and consumer markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-104028","json":"https://secwatch.observer/filing/0001104659-25-104028.json","markdown":"https://secwatch.observer/filing/0001104659-25-104028.md","text":"https://secwatch.observer/filing/0001104659-25-104028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023016/000110465925104028/0001104659-25-104028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023016/000110465925104028/tm2529778d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:26:21.725594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}